Coma au décours d'une chimiothérapie. Et si le 5 FU était en cause ? - 26/03/08
Frédéric Heluwaert [1 et 4],
Charles Santre [2],
Claude Martin [3],
Marie-Noëlle Hilleret [4],
Denis Martin [1]
Voir les affiliationsComa following chemotherapy: is 5FU implicated? Discussion about on case-report |
5FU is one of the most frequently used antioncogenic and cytostatic drug in digestive oncology. It may cause severe adverse events, such as encephalopathy, possibly based on hyperammoniemia, and may lead to coma. We report here the case of a coma with a favorable outcome following 5FU chemotherapy. As any other etiologic findings came to light, hyperammoniemia was discussed as a credible cause.
Plan
© 2006 Elsevier Masson SAS. Tous droits réservés.
Vol 30 - N° 2
P. 325-326 - février 2006 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.